Abstract
Objectives
To conduct a systematic literature review to evaluate the global incidence of intraventricular hemorrhage grade 2–4 among extremely preterm infants.
Methods
We performed searches in MEDLINE and Embase for intraventricular hemorrhage and prematurity cited in English language observational studies published from May 2006 to October 2017. Included studies analyzed data from infants born at ≤28 weeks’ gestational age and reported on intraventricular hemorrhage epidemiology.
Results
Ninety-eight eligible studies encompassed 39 articles from Europe, 31 from North America, 25 from Asia, five from Oceania, and none from Africa or South America; both Europe and North America were included in two publications. The reported global incidence range of intraventricular hemorrhage grade 3–4 was 5–52% (Europe: 5–52%; North America: 8–22%; Asia: 5–36%; Oceania: 8–13%). When only population-based studies were included, the incidence range of intraventricular hemorrhage grade 3–4 was 6–22%. The incidence range of intraventricular hemorrhage grade 2 was infrequently documented and ranged from 5–19% (including population-based studies). The incidence of intraventricular hemorrhage was generally inversely related to gestational age.
Conclusions
Intraventricular hemorrhage is a frequent complication of extremely preterm birth. Intraventricular hemorrhage incidence range varies by region, and the global incidence of intraventricular hemorrhage grade 2 is not well documented.
Introduction
Intraventricular hemorrhage (IVH) in preterm infants occurs when a germinal matrix hemorrhage ruptures through the ependyma into the lateral ventricle [1], [2]. One of the most commonly used classification systems divides the severity of the IVH clinical spectrum into four grades: IVH grades 1 and 2 involve mild bleeding that is often self-limiting, and IVH grades 3 and 4 involve moderate to severe bleeding [3].
Preterm infants with IVH grade 3–4 are at high risk of death or of developing progressive ventricular dilatation leading to posthemorrhagic hydrocephalus [4], [5], [6], which may require neurosurgical intervention, for example shunt surgery, a procedure that carries a risk of complications [6], [7], [8], [9]. IVH grades 3 and 4, with or without documented complications, place affected neonates at risk for long-term neurologic and neurodevelopmental disability, including seizures, cognitive and executive function impairment, and cerebral palsy [10], [11], [12]. Low-grade IVH in extremely preterm infants has also been associated with adverse neurodevelopmental outcomes [13].
The advances in neonatal intensive care that have improved the survival of extremely preterm infants have, by extension, led to a relative increase in the number of infants at high risk of developing IVH [10], [14], [15]. The reported incidence of IVH in preterm infants in North America declined during the 1980s [16], but more recent studies have reported a stable or increasing trend [17], [18], [19]. A greater understanding of the changing epidemiology of comorbidities among extremely preterm infants may enhance the measurement of disease burden, allocation of public health resources, and objectives of clinical research. Therefore, we undertook a systematic review of the published literature to report incidence estimates for IVH grade 2–4 in this vulnerable patient population.
Methods
Search strategy
The study was conducted according to Preferred Items for Systematic Review and Meta-Analyses (PRISMA) recommendations [20]. The IVH-related searches were nested within a larger systematic literature review that examined multiple neonatal comorbidities, and the study methods have been described previously [21]. In brief, we developed search terms based on medical subject headings, Emtree terms (Embase), and free-text words associated with prematurity and IVH (Supplementary Tables 1 and 2). The IVH complication “periventricular hemorrhagic infarction” was not included in the search terms. A specific IVH grade or severity was not included in the search terms.
Both peer-reviewed articles and conference abstracts were included in the review. As described previously [21], searches were initially conducted in MEDLINE and Embase for conference abstracts and articles published from May 2006 to May 2016. Subsequently, an updated search was conducted using an identical approach that captured abstracts and articles published from May 2016 to October 2017. Retrieved citations and abstracts were screened by K.K. and Evidera research staff. During the course of the project, grade 2 IVH became a severity level of particular interest and a supplemental, targeted, nonsystematic review was conducted in 2017 with the aim of identifying additional articles on IVH grade 2 not previously identified in the systematic literature review. IVH grade ≥2 is of interest because this population could be targeted for potential future treatment of IVH.
Study selection
The aim of the current review was to identify the global incidence of IVH among extremely preterm infants. The World Health Organization defines extreme prematurity as birth at <28 weeks’ gestational age (GA) [22]. We found that not all studies stratified IVH frequency according to this cutoff and we felt that excluding papers reporting IVH among infants born at 28 weeks’ GA would potentially exclude data that were relevant to providing a full picture of this morbidity. Therefore, studies that included information on infants born at ≤28 weeks’ GA were included in the current study.
IVH is graded most often according to Papile et al. criteria (grade 1: germinal matrix hemorrhage; grade 2: IVH without ventricular dilatation; grade 3: IVH with ventricular dilatation; and grade 4: IVH extending into adjacent brain parenchyma) [3]. IVH is also graded according to Volpe (grade 1: germinal matrix hemorrhage with no or minimal IVH; grade 2: IVH in 10–50% of ventricular area on parasagittal view; grade 3: IVH in >50% of ventricular area on parasagittal view, usually distends lateral ventricle; periventricular hemorrhagic infarction [often referred to as grade 4 IVH]) [23]. The definition of IVH was not included in the protocol for the current study. Where available, the definitions used in included studies are reported for context. No a priori case definition inclusion criteria were used to determine study eligibility.
Eligible publications were prospective and retrospective observational studies published in English. Articles reporting data from the same study population or data source were grouped to avoid duplicate counting. The incidence of IVH was reported as a range.
Data extraction
A standardized Microsoft Excel® form was utilized to extract relevant information from each eligible publication, which included incidence of IVH and definitions of IVH. Data on IVH severity and GA at birth were extracted where available. Note: only IVH grades 2, 3, 4, and overall grade are included in the current analysis; incidence of IVH grade 1 was extracted, but the data were not summarized and are not included in the current review. Grade 1 was outside the scope of the current study because it is more common than grades 2, 3 and 4 and because it is not generally considered to have a clinical impact on later neurodevelopmental outcomes; our focus was on the more severe grades of IVH.
Ethical approval
The conducted research is not related to either human or animal use.
Results
Literature search results
The parent MEDLINE and Embase searches on neonatal comorbidities identified 3,952 articles (Figure 1). A total of 2,198 articles were excluded according to study exclusion criteria. Of 1,754 articles retrieved and reviewed in full text, 1,660 were rejected for not meeting IVH-related study inclusion criteria. Thus, 94 articles met the study inclusion criteria and were included in the review. An additional four articles were identified from the grade 2 targeted literature review [5], [24], [25], [26], bringing the total number of included articles to 98.
In the systematic literature review, 38 articles (28 distinct data sources) reported data from Europe [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57], [58], [59], [60], [61], [62], [63], [64], 29 articles (15 data sources) from North America [15], [27], [28], [65], [66], [67], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79], [80], [81], [82], [83], [84], [85], [86], [87], [88], [89], [90], 24 articles (19 data sources) from Asia [91], [92], [93], [94], [95], [96], [97], [98], [99], [100], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110], [111], [112], [113], [114], and five articles (four data sources) from Oceania (Australia only) [115], [116], [117], [118], [119]. Two articles reported data from both Europe and North America [27], [28]. No published data from Africa or South America reporting the incidence/prevalence of IVH were found. The additional targeted search yielded one additional article reporting data from Europe [24], two articles reporting data from North America (two data sources) [25], [26], and one article from Asia [5].
Heterogeneity was detected across studies with respect to study setting, IVH and preterm definitions, and sample size (Supplementary Tables 3–5). The majority of studies (57.4% [54/94]) reporting IVH incidence data defined IVH according to Papile et al. criteria [3]. However, a significant minority either did not report the IVH definition used or used different criteria. Some studies imposed specific criteria when calculating IVH incidence, such as only considering infants who had survived to a specific point in time (e.g., to discharge).
Global incidence of IVH by severity; grade 3–4, grade 2 and overall
The overall reported incidence range of IVH grade 3–4 reported in the 98 identified articles was 5–52% (Table 1). The majority of studies in Europe, North America, Asia, and Oceania reported an IVH grade 3–4 incidence of <20% (Supplementary Tables 3–5). The reported incidence range of IVH grade 3–4 was 6–22% when only the 18 population-based sources (from studies that reported incidence of IVH grade 3–4) were included.
Reported incidence of intraventricular hemorrhage grade 3–4 among infants born at ≤28 weeks’ gestational age, by region.
Region | Incidence range (no. of distinct data sources) | |
---|---|---|
All sources | Population-based studies | |
Europe | 5–52% (28) | 6–17% (8) |
North America | 8–22% (14) | 11–22% (5) |
Asia | 5–36% (19) | 10–14% (3) |
Oceania | 8–13% (4)a | 12–13% (2)a |
Africa | No publications identified | No publications identified |
South America | No publications identified | No publications identified |
-
aAll Australian sources.
As shown in Table 2, the incidence of IVH grade 2 ranged from 5 to 19% among the 10 data sources (11 articles) identified by the searches [5], [15], [24], [25], [26], [59], [61], [73], [101], [104], [109]. When only population-based studies were included (conducted in North America and Asia), the reported incidence range of IVH grade 2 was 5–11%.
Reported incidence of intraventricular hemorrhage grade 2 among infants born at ≤28 weeks’ gestational age, by region.
Region | Incidence range (no. of distinct data sources) | |
---|---|---|
All sources | Population-based studies | |
Europe | 8–14% (3) | No publications found |
North America | 5–14% (3)a | 5–6% (1) |
Asia | 6–19% (4) | 11% (1)b |
Oceania | No publications identified | No publications identified |
Africa | No publications identified | No publications identified |
South America | No publications identified | No publications identified |
-
aAll US sources. bKorean source.
The overall global reported incidence of IVH (all grades) ranged from 7 to 72% (Supplementary Tables 3–5). When only population studies were included, the incidence was 7–49% (among infants with spontaneous intestinal perforation).
Europe
The 29 distinct European data sources included 18 single-institution, three multi-institution, and eight population-based studies. Sample sizes ranged from 27 to 1,498 infants (Supplementary Table 3). The proportion of extremely preterm infants in Europe who developed IVH grade 3–4 ranged from 5% of 99 infants born at <28 weeks’ GA from the University Hospital of Antwerp, Belgium [29] to 52% of 247 infants born at 25–28 weeks’ GA during 2007–2010 in three Romanian hospitals [52], [53]. However, a later analysis revealed that the incidence of IVH grade 3–4 in the three Romanian hospitals was much lower (12%) among infants who were born during 2011–2014 [53]. The proportion of extremely premature infants who developed IVH grade 3–4 in population-based studies ranged from 6 to 8% of infants born at 24–27 weeks’ GA from the Swiss Neonatal Network [30], [31], to 17% of infants with a birth weight of <1,000 g (58% born at 22–26 weeks’ GA) in Finland [57]. In the largest population-based study, the incidence of IVH grade 3–4 was 11–17% among 599–1,498 infants born at 23–28 weeks’ GA in all maternity units in France (EPIPAGE-2) [49], [50], [51].
In three data sources, IVH grade 2 incidence was 8% of 132 infants born at 23–27 weeks’ GA from a single institution in Switzerland [61], 8% of 84 infants born at ≤28 weeks’ GA from a single institution in Italy [24], and 14% of 279 infants born at ≤28 weeks’ GA from a single institution in Germany [59].
For the two European sources reporting IVH incidence with respect to GA at birth (one multi-institution and one population-based), infants born at the younger end of the range of extreme prematurity tended to have a higher incidence of IVH grade 3–4, although findings from the later Romanian study were more variable (Figure 2) [32], [52], [53]. In the population-based study, 36% of infants born at 23 weeks’ GA had IVH grade 3–4 compared with an incidence of 10% for infants born at 27 weeks’ GA [32].

Incidence of IVH grade 3–4 and IVH grade 2, stratified by GA at birth.
aData collected at three institutions. bDenominator for incidence included only infants surviving to at least 18–24 months’ corrected age. cFrom the sonogram with the most severe findings. Proportions were determined among those who had sonograms performed within 28 days after birth. dAmong infants who had cranial sonography within 28 days. eDefinition of IVH not reported. IVH, intraventricular hemorrhage; NR, not reported; wGA, weeks’ gestational age.
North America
The 17 North American data sources included eight single-institution, two multi-institution, and seven population-based studies (Supplementary Table 4). The range of sample sizes was 40–12,705 infants. Across North American studies, the incidence of IVH was 8% among infants born at 24–28 weeks’ GA at Rainbow Babies & Children’s Hospital in the United States [65] to 22% (IVH or periventricular leukomalacia) among infants born at <29 weeks’ GA in the Canadian Neonatal Network [79]. An IVH incidence of 12% was observed in the largest population-based study (Pediatrix; n=12,705) [86]. In addition, analysis of the National Institute of Child Health and Human Development (NICHD) Neonatal Research Network revealed that 25% of infants born with an extremely low birth weight at 23–28 weeks’ GA had intracranial hemorrhage [85].
All three North American data sources reporting IVH grade 2 incidence were from the United States: 5% of infants born at ≤27 weeks’ GA in an Oklahoma institution [26], 5–6% of infants born at 22–28 weeks’ GA with a birth weight of 401–1,500 g from the Neonatal Research Network [15], [73], and 14% of infants with a birth weight <1,000 g (mean GA: 25.6 weeks) at an institution in Virginia [25]. The incidence of IVH grade 2 ranged from 2 to 12% across the individual Neonatal Research Network centers between 2003 and 2007 among infants born at 22–28 weeks’ GA who had survived for >12 h [15].
As in Europe, IVH grade 3–4 incidence was highest among low-GA infants (Figure 2) [15], [86]. In the two population-based studies reporting such data, IVH incidences were 36 and 27% among infants born at 23 weeks’ GA, falling to 11 and 5%, respectively, among infants born at 27 weeks’ GA [15], [86]. IVH incidences among infants born at 28 weeks’ GA were 7 and 3% [15], [86]. Data from the Neonatal Research Network also showed lower IVH grade 2 incidence as GA at birth increased (9% at 23 weeks’ GA and 4% at 28 weeks’ GA) [15].
Asia and Oceania
The 20 Asian data sources (14 single-institution; three multi-institution; three population-based) and the four from Oceania (two single-institution; two population-based; all Australian sources) reported sample sizes from 41 to 9,149 infants (Supplementary Table 5). The reported incidence of severe IVH was 5–36% in Asia, and 8–13% in Australia (Table 1). Two of the four Australian sources included infants born at ≤29 weeks’ GA [116], [117], [119]. In the four population-based studies, the incidence of IVH grade 3–4 among infants born at ≤28 weeks’ GA was 10–12% in Japan [98], [99], 14% in Taiwan [103], and 12–13% in Australia [115], [117], [119]. Our separate targeted search identified population-based data from 55 Korean Neonatal Network centers (2013–2014) showing an IVH grade 3–4 incidence of 10% among 2,323 infants born at ≤28 weeks’ GA [5].
In the three single-institution studies conducted in Asia, IVH grade 2 incidence was 6% among infants born at 23–26 weeks’ GA at a hospital in Oman [104], 10% among infants born at 23–28 weeks’ GA at a single institution in Singapore [101], and 19% among infants born at <25 weeks’ GA at a medical center in Korea [109]. The Korean Neonatal Network study reported an IVH grade 2 incidence of 11% [5].
Asian studies showed an inverse relationship between IVH incidence and GA at birth [5], [94]. Figure 2 shows a substantial reduction in IVH grade 3–4 incidence as GA increased among 322 infants admitted to a neonatal intensive care unit (ICU) in Hong Kong, China [94]. IVH incidence in that study was 27% for infants born at 23 weeks’ GA and 4% for infants born at 28 weeks’ GA. In the Korean Neonatal Network study [5], IVH grade 3–4 incidence was 37, 20, and 9% among infants born at 23–24, 25–26, and 27–28 weeks’ GA, respectively. Corresponding incidences of IVH grade ≥2 in these GA cohorts were 51, 32, and 17% [5].
Discussion
Data from studies conducted in Europe, North America, Asia, and Oceania show that IVH grade 3–4 is a frequent complication following extremely preterm birth. The broad incidence range for IVH grade 3–4 (5–52%) is indicative of differing birth weights and GAs of neonates among study populations, and variable ICU practices and diagnostic criteria across study institutions. For instance, the five-fold higher risk of IVH grade 3–4 in Romanian ICUs between 2007 and 2010 than in centers of excellence worldwide has been attributed to the restrained application of active perinatal management [52]. Subsequent adoption of perinatal and neonatal interventions such as surfactant therapy and cesarean delivery in Romanian ICUs between 2011 and 2014 resulted in a reduced incidence of IVH grade 3–4 that approximated population-based data from centers of excellence (12 vs. 6–22%) [53].
Low-grade IVH is not generally considered to be of clinical significance, which could explain the low number of articles (n=11) we identified that reported the incidence of grade 2 IVH. However, there is evidence that low-grade hemorrhages increase the risk for neurodevelopmental impairment in preterm infants [13]. Observations that the incidence of IVH is inversely related to weeks’ GA at birth were confirmed by several studies for both IVH grade 3–4 and IVH grade 2. The trends appeared linear and were most obvious when assessing data from the large population-based studies.
These findings suggest that a more uniform diagnosis of IVH is necessary when reporting observational data, which requires stratification by GA and birth weight. Case definitions of IVH were not consistent among included studies. Although IVH was frequently defined according to Papile et al. criteria [3], other definitions (e.g., Volpe) were also utilized. Neonatal survival rates also affected the reported incidence of IVH; many infants who died before a study-specific time point or who had congenital anomalies were excluded from incidence calculations.
Our analysis has some limitations, some of which relate to the wider study and have been discussed previously [21]. These include differences in the study definitions relating to IVH and extremely preterm birth. Specific criteria for calculating IVH incidence were not stipulated or stated explicitly in some studies. It could not be determined routinely whether or not IVH incidence included all live-born neonates. Hence, IVH incidence could have been underestimated. Data collection methods and analysis in included studies varied between institutions. Further, information on the timing of the assessments used to diagnose IVH and the rigor of the readings were not widely reported in included studies. Cranial ultrasound (CUS) is the most common method used to diagnose neonatal brain injuries and has the advantage of being readily available and non-invasive. However, grade 1 and 2 lesions can be difficult to diagnose with CUS, and subtle white matter injury may not be recognized [120], [121]. Magnetic resonance imaging has been shown to better detect subtle white matter lesions than CUS [122]. The current study focused on IVH; however, white matter injury (e.g., periventricular leukomalacia) is a major determinant of neurodevelopmental outcome and can accompany severe IVH. Nonetheless, our extensive systematic literature review identified a number of studies that enrolled a high number of infants, and which reported consistent findings for IVH incidence by GA. This observation supports the method by which we stratified our search results by study design and emphasized data from population-based studies, as they are more generalizable than single-site studies.
Conclusions
In conclusion, IVH incidence data indicate that the likelihood of an extremely preterm infant having IVH grade 3–4 is high, particularly among infants with the lowest GAs. More data on the incidence of IVH grade 2 are required to quantify disease burden. The development of novel therapies is essential to help reduce or prevent IVH occurrence.
Funding source: Takeda Pharmaceutical Company
Acknowledgments
John Germak, MD, of Takeda, reviewed the draft for medical accuracy. Juliana F. M. Lewis, MPH, formerly of Evidera, participated in the systematic literature search and analysis of results. Under direction of the authors and in accordance with GPP3 guidelines, Malcolm Darkes, PhD, MPS, and Rosalind Bonomally, MSc, of Excel Medical Affairs, provided writing assistance for this publication. Shire, a Takeda company, provided funding to Excel Medical Affairs for medical writing support.
-
Research funding: This study was funded by Shire, a Takeda company.
-
Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.
-
Competing interests: C.S. is an employee of and holds stock/stock options in Takeda. K.D.K is an employee of Evidera and was a paid consultant to Shire, a Takeda company, in relation to this study. S.P.S was an employee of Takeda at the time of the study.
References
1. Ballabh, P. Intraventricular hemorrhage in premature infants: mechanism of disease. Pediatr Res 2010;67:1–8. https://doi.org/10.1203/pdr.0b013e3181c1b176.Search in Google Scholar
2. Ment, LR, Ådén, U, Lin, A, Kwon, SH, Choi, M, Hallman, M, et al.. Gene-environment interactions in severe intraventricular hemorrhage of preterm neonates. Pediatr Res 2014;75:241–50. https://doi.org/10.1038/pr.2013.195.Search in Google Scholar
3. Papile, LA, Burstein, J, Burstein, R, Koffler, H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr 1978;92:529–34. https://doi.org/10.1016/s0022-3476(78)80282-0.Search in Google Scholar
4. Murphy, BP, Inder, TE, Rooks, V, Taylor, GA, Anderson, NJ, Mogridge, N, et al.. Posthaemorrhagic ventricular dilatation in the premature infant: natural history and predictors of outcome. Arch Dis Child Fetal Neonatal Ed 2002;87:F37–41. https://doi.org/10.1136/fn.87.1.f37.Search in Google Scholar PubMed PubMed Central
5. Ahn, SY, Shim, SY, Sung, IK. Intraventricular hemorrhage and post hemorrhagic hydrocephalus among very-low-birth-weight infants in Korea. J Korean Med Sci 2015;30:S52–8. https://doi.org/10.3346/jkms.2015.30.s1.s52.Search in Google Scholar PubMed PubMed Central
6. Brouwer, AJ, Groenendaal, F, Han, KS, de Vries, LS. Treatment of neonatal progressive ventricular dilatation: a single-centre experience. J Matern Fetal Neonatal Med 2015;28:2273–9. https://doi.org/10.3109/14767058.2013.796167.Search in Google Scholar PubMed
7. Kennedy, CR, Ayers, S, Campbell, MJ, Elbourne, D, Hope, P, Johnson, A. Randomized, controlled trial of acetazolamide and furosemide in posthemorrhagic ventricular dilation in infancy: follow-up at 1 year. Pediatrics 2001;108:597–607. https://doi.org/10.1542/peds.108.3.597.Search in Google Scholar PubMed
8. Ventriculomegaly Trial Group. Randomised trial of early tapping in neonatal posthaemorrhagic ventricular dilatation. Arch Dis Child 1990;65:3–10.10.1136/adc.65.1_Spec_No.3Search in Google Scholar PubMed PubMed Central
9. Gilard, V, Chadie, A, Ferracci, FX, Brasseur-Daudruy, M, Proust, F, Marret, S, et al.. Post hemorrhagic hydrocephalus and neurodevelopmental outcomes in a context of neonatal intraventricular hemorrhage: an institutional experience in 122 preterm children. BMC Pediatr 2018;18:288. https://doi.org/10.1186/s12887-018-1249-x.Search in Google Scholar PubMed PubMed Central
10. Vohr, BR, Wright, LL, Dusick, AM, Mele, L, Verter, J, Steichen, JJ, et al.. Neurodevelopmental and functional outcomes of extremely low birth weight infants in the National Institute of Child Health and Human Development Neonatal Research Network, 1993–1994. Pediatrics 2000;105:1216–26. https://doi.org/10.1542/peds.105.6.1216.Search in Google Scholar PubMed
11. Vohr, BR, Allan, WC, Westerveld, M, Schneider, KC, Katz, KH, Makuch, RW, et al.. School-age outcomes of very low birth weight infants in the indomethacin intraventricular hemorrhage prevention trial. Pediatrics 2003;111:e340–6. https://doi.org/10.1542/peds.111.4.e340.Search in Google Scholar PubMed
12. Radic, JA, Vincer, M, McNeely, PD. Outcomes of intraventricular hemorrhage and posthemorrhagic hydrocephalus in a population-based cohort of very preterm infants born to residents of Nova Scotia from 1993 to 2010. J Neurosurg Pediatr 2015;15:580–8. https://doi.org/10.3171/2014.11.peds14364.Search in Google Scholar
13. Bolisetty, S, Dhawan, A, Abdel-Latif, M, Bajuk, B, Stack, J, Oei, JL, et al.. Intraventricular hemorrhage and neurodevelopmental outcomes in extreme preterm infants. Pediatrics 2014;133:55–62. https://doi.org/10.1542/peds.2013-0372.Search in Google Scholar PubMed
14. Stoll, BJ, Hansen, NI, Bell, EF, Walsh, MC, Carlo, WA, Shankaran, S, et al.. Trends in care practices, morbidity, and mortality of extremely preterm neonates 1993–2012. J Am Med Assoc 2015;314:1039–51. https://doi.org/10.1001/jama.2015.10244.Search in Google Scholar PubMed PubMed Central
15. Stoll, BJ, Hansen, NI, Bell, EF, Shankaran, S, Laptook, AR, Walsh, MC, et al.. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics 2010;126:443–56. https://doi.org/10.1542/peds.2009-2959.Search in Google Scholar PubMed PubMed Central
16. Philip, AG, Allan, WC, Tito, AM, Wheeler, LR. Intraventricular hemorrhage in preterm infants: declining incidence in the 1980s. Pediatrics 1989;84:797–801.10.1542/peds.84.5.797Search in Google Scholar
17. Radic, JA, Vincer, M, McNeely, PD. Temporal trends of intraventricular hemorrhage of prematurity in Nova Scotia from 1993 to 2012. J Neurosurg Pediatr 2015;15:573–9. https://doi.org/10.3171/2014.11.peds14363.Search in Google Scholar PubMed
18. Jain, NJ, Kruse, LK, Demissie, K, Khandelwal, M. Impact of mode of delivery on neonatal complications: trends between 1997 and 2005. J Matern Fetal Neonatal Med 2009;22:491–500. https://doi.org/10.1080/14767050902769982.Search in Google Scholar PubMed
19. Christian, EA, Jin, DL, Attenello, F, Wen, T, Cen, S, Mack, WJ, et al.. Trends in hospitalization of preterm infants with intraventricular hemorrhage and hydrocephalus in the United States, 2000–2010. J Neurosurg Pediatr 2016;17:260–9. https://doi.org/10.3171/2015.7.peds15140.Search in Google Scholar PubMed
20. Moher, D, Liberati, A, Tetzlaff, J, Altman, DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009;339:b2535. https://doi.org/10.1136/bmj.b2535.Search in Google Scholar PubMed PubMed Central
21. Siffel, C, Kistler, KD, Lewis, JFM, Sarda, SP. Global incidence of bronchopulmonary dysplasia among extremely preterm infants: a systematic literature review. J Matern Fetal Neonatal Med 2019:1–11. https://doi.org/10.1080/14767058.2019.1646240.Search in Google Scholar PubMed
22. World Health Organization. Preterm birth; 2018. Available from: http://www.who.int/mediacentre/factsheets/fs363/en/ [Accessed 22 Jul 2019].Search in Google Scholar
23. Volpe, JJ. Neurology of the newborn, 5th ed. Philadelphia, PA: Saunders, Elsevier; 2008.Search in Google Scholar
24. Dani, C, Poggi, C, Bertini, G, Pratesi, S, Tommaso, MD, Scarselli, G, et al.. Method of delivery and intraventricular haemorrhage in extremely preterm infants. J Matern Fetal Neonatal Med 2010;23:1419–23. https://doi.org/10.3109/14767051003678218.Search in Google Scholar PubMed
25. Fairchild, KD, Sinkin, RA, Davalian, F, Blackman, AE, Swanson, JR, Matsumoto, JA, et al.. Abnormal heart rate characteristics are associated with abnormal neuroimaging and outcomes in extremely low birth weight infants. J Perinatol 2014;34:375–9. https://doi.org/10.1038/jp.2014.18.Search in Google Scholar PubMed
26. Noori, S, McCoy, M, Anderson, MP, Ramji, F, Seri, I. Changes in cardiac function and cerebral blood flow in relation to peri/intraventricular hemorrhage in extremely preterm infants. J Pediatr 2014;164:264–70. https://doi.org/10.1016/j.jpeds.2013.09.045.Search in Google Scholar PubMed
27. Levy, PT, El-Khuffash, A, Patel, MD, Breatnach, CR, James, AT, Sanchez, AA, et al.. Maturational patterns of systolic ventricular deformation mechanics by two-dimensional speckle-tracking echocardiography in preterm infants over the first year of age. J Am Soc Echocardiogr 2017;30:685–98. https://doi.org/10.1016/j.echo.2017.03.003.Search in Google Scholar PubMed PubMed Central
28. Vanpée, M, Walfridsson-Schultz, U, Katz-Salamon, M, Zupancic, JAF, Pursley, D, Jónsson, B. Resuscitation and ventilation strategies for extremely preterm infants: a comparison study between two neonatal centers in Boston and Stockholm. Acta Paediatr 2007;96:10–6. https://doi.org/10.1111/j.1651-2227.2007.00063.x.Search in Google Scholar PubMed
29. Van Laere, D, O’Toole, JM, Voeten, M, McKiernan, J, Boylan, GB, Dempsey, E. Decreased variability and low values of perfusion index on day one are associated with adverse outcome in extremely preterm infants. J Pediatr 2016;178:119–24. https://doi.org/10.1016/j.jpeds.2016.08.008.Search in Google Scholar PubMed
30. Schlapbach, LJ, Adams, M, Proietti, E, Aebischer, M, Grunt, S, Borradori-Tolsa, C, et al.. Outcome at two years of age in a Swiss national cohort of extremely preterm infants born between 2000 and 2008. BMC Pediatr 2012;12:198. https://doi.org/10.1186/1471-2431-12-198.Search in Google Scholar PubMed PubMed Central
31. Schlapbach, LJ, Aebischer, M, Adams, M, Natalucci, G, Bonhoeffer, J, Latzin, P, et al.. Impact of sepsis on neurodevelopmental outcome in a Swiss National Cohort of extremely premature infants. Pediatrics 2011;128:e348–57. https://doi.org/10.1542/peds.2010-3338.Search in Google Scholar PubMed
32. Gerull, R, Brauer, V, Bassler, D, Laubscher, B, Pfister, RE, Nelle, M, et al.. Incidence of retinopathy of prematurity (ROP) and ROP treatment in Switzerland 2006–2015: a population-based analysis. Arch Dis Child Fetal Neonatal Ed 2017;103:F337–42. https://doi.org/10.1136/archdischild-2017-313574.Search in Google Scholar PubMed
33. de Waal, CG, Weisglas-Kuperus, N, van Goudoever, JB, Walther, FJ. Mortality, neonatal morbidity and two year follow-up of extremely preterm infants born in The Netherlands in 2007. PloS One 2012;7:e41302. https://doi.org/10.1371/journal.pone.0041302.Search in Google Scholar PubMed PubMed Central
34. Soudée, S, Vuillemin, L, Alberti, C, Mohamed, D, Becquet, O, Farnoux, C, et al.. Fetal growth restriction is worse than extreme prematurity for the developing lung. Neonatology 2014;106:304–10. https://doi.org/10.1159/000360842.Search in Google Scholar PubMed
35. Morgillo, D, Morgillo-Mitchell, J, Fontanta, M, Steurer, M, Schmitt-Mechelke, T, Bauder, F, et al.. Outcome of extremely low gestational age newborns (ELGANs) following a pro-active treatment approach: a Swiss single centre experience over 10 years. Swiss Med Wkly 2014;144:w14014. https://doi.org/10.4414/smw.2014.14014.Search in Google Scholar PubMed
36. Hergenhan, A, Steurer, M, Berger, TM. Gestational age-adapted oxygen saturation targeting and outcome of extremely low gestational age neonates (ELGANs). Swiss Med Wkly 2015;145:w14197. https://doi.org/10.4414/smw.2015.14197.Search in Google Scholar PubMed
37. Stensvold, HJ, Klingenberg, C, Stoen, R, Moster, D, Braekke, K, Guthe, HJ, et al.. Neonatal morbidity and 1-year survival of extremely preterm infants. Pediatrics 2017;139:e20161821. https://doi.org/10.1542/peds.2016-1821.Search in Google Scholar PubMed
38. Westby Wold, SH, Sommerfelt, K, Reigstad, H, Rønnestad, A, Medbø, S, Farstad, T, et al.. Neonatal mortality and morbidity in extremely preterm small for gestational age infants: a population based study. Arch Dis Child Fetal Neonatal Ed 2009;94:F363–7. https://doi.org/10.1136/adc.2009.157800.Search in Google Scholar PubMed
39. Zecca, E, de Luca, D, Costa, S, Marras, M, de Turris, P, Romagnoli, C. Delivery room strategies and outcomes in preterm infants with gestational age 24–28 weeks. J Matern Fetal Neonatal Med 2006;19:569–74. https://doi.org/10.1080/14767050600736739.Search in Google Scholar PubMed
40. Hasselager, AB, Børch, K, Pryds, OA. Improvement in perinatal care for extremely premature infants in Denmark from 1994 to 2011. Dan Med J 2016;63:A5182.Search in Google Scholar
41. Durrmeyer, X, Kayem, G, Sinico, M, Dassieu, G, Danan, C, Decobert, F. Perinatal risk factors for bronchopulmonary dysplasia in extremely low gestational age infants: a pregnancy disorder-based approach. J Pediatr 2012;160:578–83. https://doi.org/10.1016/j.jpeds.2011.09.025.Search in Google Scholar PubMed
42. Mehler, K, Grimme, J, Abele, J, Huenseler, C, Roth, B, Kribs, A. Outcome of extremely low gestational age newborns after introduction of a revised protocol to assist preterm infants in their transition to extrauterine life. Acta Paediatr 2012;101:1232–9. https://doi.org/10.1111/apa.12015.Search in Google Scholar PubMed
43. Mehler, K, Oberthuer, A, Keller, T, Becker, I, Valter, M, Roth, B, et al.. Survival among infants born at 22 or 23 weeks’ gestation following active prenatal and postnatal care. JAMA Pediatr 2016;170:671–7. https://doi.org/10.1001/jamapediatrics.2016.0207.Search in Google Scholar PubMed
44. Vinnars, MT, Papadogiannakis, N, Nasiell, J, Holmström, G, Westgren, M. Placental pathology in relation to stillbirth and neonatal outcome in an extremely preterm population: a prospective cohort study. Acta Obstet Gynecol Scand 2015;94:584–90. https://doi.org/10.1111/aogs.12610.Search in Google Scholar PubMed
45. EXPRESS Group. Incidence of and risk factors for neonatal morbidity after active perinatal care: extremely preterm infants study in Sweden (EXPRESS). Acta Paediatr 2010;99:978–92. https://doi.org/10.1111/j.1651-2227.2010.01846.x.Search in Google Scholar PubMed
46. EXPRESS Group. One-year survival of extremely preterm infants after active perinatal care in Sweden. J Am Med Assoc 2009;301:2225–33.10.1001/jama.2009.771Search in Google Scholar PubMed
47. Teig, N, Weitkämper, A, Rothermel, J, Bigge, N, Lilienthal, E, Rossler, L, et al.. Observational study on less invasive surfactant administration (LISA) in preterm infants <29 weeks – short and long-term outcomes. Z Geburtshilfe Neonatol 2015;219:266–73. https://doi.org/10.1055/s-0035-1547295.Search in Google Scholar PubMed
48. Zeitlin, J, Ancel, PY, Delmas, D, Bréart, G, Papiernik, E. Changes in care and outcome of very preterm babies in the Parisian region between 1998 and 2003. Arch Dis Child Fetal Neonatal Ed 2010;95:F188–93. https://doi.org/10.1136/adc.2008.156745.Search in Google Scholar PubMed
49. Rozé, JC, Cambonie, G, Marchand-Martin, L, Gournay, V, Durrmeyer, X, Durox, M, et al.. Association between early screening for patent ductus arteriosus and in-hospital mortality among extremely preterm infants. J Am Med Assoc 2015;313:2441–8. https://doi.org/10.1001/jama.2015.6734.Search in Google Scholar PubMed
50. Ancel, PY, Goffinet, F, Kuhn, P, Langer, B, Matis, J, Hernandorena, X, et al.. Survival and morbidity of preterm children born at 22 through 34 weeks’ gestation in France in 2011: results of the EPIPAGE-2 cohort study. JAMA Pediatr 2015;169:230–8. https://doi.org/10.1001/jamapediatrics.2014.3351.Search in Google Scholar PubMed
51. Durrmeyer, X, Marchand-Martin, L, Porcher, R, Gascoin, G, Roze, JC, Storme, L, et al.. Abstention or intervention for isolated hypotension in the first 3 days of life in extremely preterm infants: association with short-term outcomes in the EPIPAGE 2 cohort study. Arch Dis Child Fetal Neonatal Ed 2017;102:490–6. https://doi.org/10.1136/archdischild-2016-312104.Search in Google Scholar PubMed
52. Suciu, LM, Puscasiu, L, Szabo, B, Cucerea, M, Ognean, ML, Oprea, I, et al.. Mortality and morbidity of very preterm infants in Romania: how are we doing? Pediatr Int 2014;56:200–6. https://doi.org/10.1111/ped.12219.Search in Google Scholar PubMed
53. Suciu, LM, Puscasiu, L, Cucerea, M, Szabo, B, Ognean, ML, Petrescu, O, et al.. Trends in outcomes of very preterm infants in Romania: a tale of three cities. Pediatr Int 2017;59:1157–64. https://doi.org/10.1111/ped.13415.Search in Google Scholar PubMed
54. Gawlowski, Z, Aladangady, N, Coen, PG. Hypernatraemia in preterm infants born at less than 27 weeks gestation. J Paediatr Child Health 2006;42:771–4. https://doi.org/10.1111/j.1440-1754.2006.00975.x.Search in Google Scholar PubMed
55. Klebermass-Schrehof, K, Wald, M, Schwindt, J, Grill, A, Prusa, AR, Haiden, N, et al.. Less invasive surfactant administration in extremely preterm infants: impact on mortality and morbidity. Neonatology 2013;103:252–8. https://doi.org/10.1159/000346521.Search in Google Scholar PubMed
56. Hummler, HD, Parys, E, Mayer, B, Essers, J, Fuchs, H, Schmid, M. Risk indicators for air leaks in preterm infants exposed to restrictive use of endotracheal intubation. Neonatology 2015;108:1–7. https://doi.org/10.1159/000375361.Search in Google Scholar PubMed
57. Tommiska, V, Heinonen, K, Lehtonen, L, Renlund, M, Saarela, T, Tammela, O, et al.. No improvement in outcome of nationwide extremely low birth weight infant populations between 1996–1997 and 1999–2000. Pediatrics 2007;119:29–36. https://doi.org/10.1542/peds.2006-1472.Search in Google Scholar PubMed
58. Skovgaard, AL, Zachariassen, G. Cranial ultrasound findings in preterm infants predict the development of cerebral palsy. Dan Med J 2017;64:A5330.Search in Google Scholar
59. Waitz, M, Nusser, S, Schmid, MB, Dreyhaupt, J, Reister, F, Hummler, H. Risk factors associated with intraventricular hemorrhage in preterm infants with ≤28 weeks gestational age. Klin Pädiatr 2016;228:245–50. https://doi.org/10.1055/s-0042-111689.Search in Google Scholar PubMed
60. Herber-Jonat, S, Schulze, A, Kribs, A, Roth, B, Lindner, W, Pohlandt, F. Survival and major neonatal complications in infants born between 22 0/7 and 24 6/7 weeks of gestation (1999–2003). Am J Obstet Gynecol 2006;195:16–22. https://doi.org/10.1016/j.ajog.2006.02.043.Search in Google Scholar PubMed
61. Poralla, C, Hertfelder, HJ, Oldenburg, J, Müller, A, Bartmann, P, Heep, A. Elevated interleukin-6 concentration and alterations of the coagulation system are associated with the development of intraventricular hemorrhage in extremely preterm infants. Neonatology 2012;102:270–5. https://doi.org/10.1159/000341266.Search in Google Scholar PubMed
62. Rocha, G, Guimarães, H. On the limit of viability extremely low gestational age at birth. Acta Med Port 2011;24:181–8.Search in Google Scholar
63. Szpecht, D, Nowak, I, Kwiatkowska, P, Szymankiewicz, M, Gadzinowski, J. Intraventricular hemorrhage in neonates born from 23 to 26 weeks of gestation: retrospective analysis of risk factors. Adv Clin Exp Med 2017;26:89–94. https://doi.org/10.17219/acem/65311.Search in Google Scholar PubMed
64. Mamopoulos, A, Petousis, S, Tsimpanakos, J, Masouridou, S, Kountourelli, K, Margioula-Siarkou, C, et al.. Birth weight independently affects morbidity and mortality of extremely preterm neonates. J Clin Med Res 2015;7:511–6. https://doi.org/10.14740/jocmr2075w.Search in Google Scholar PubMed PubMed Central
65. Wang, K, Difiore, JM, Martin, RJ, Rosen, CL, Hibbs, AM. Markers for severity of illness associated with decreased snoring in toddlers born ELGA. Acta Paediatr 2013;102:e39–43. https://doi.org/10.1111/apa.12033.Search in Google Scholar PubMed PubMed Central
66. Poindexter, BB, Feng, R, Schmidt, B, Aschner, JL, Ballard, RA, Hamvas, A, et al.. Comparisons and limitations of current definitions of bronchopulmonary dysplasia for the prematurity and respiratory outcomes program. Ann Am Thorac Soc 2015;12:1822–30. https://doi.org/10.1513/annalsats.201504-218oc.Search in Google Scholar PubMed PubMed Central
67. Tolia, VN, Murthy, K, McKinley, PS, Bennett, MM, Clark, RH. The effect of the national shortage of vitamin A on death or chronic lung disease in extremely low-birth-weight infants. JAMA Pediatr 2014;168:1039–44. https://doi.org/10.1001/jamapediatrics.2014.1353.Search in Google Scholar PubMed
68. Batton, DG, DeWitte, DB, Pryce, CJE. One hundred consecutive infants born at 23 weeks and resuscitated. Am J Perinatol 2011;28:299–304. https://doi.org/10.1055/s-0030-1268714.Search in Google Scholar PubMed
69. Hussaini, S, Czuzoj-Shulman, N, Spence, A, Abenhaim, HA. Survival, resuscitation and morbidities in extremely preterm infant – a retrospective cohort study [23C]. Obstet Gynecol 2017;129:36S. https://doi.org/10.1097/01.aog.0000514337.78278.f1.Search in Google Scholar
70. Carlo, WA, McDonald, SA, Fanaroff, AA, Vohr, BR, Stoll, BJ, Ehrenkranz, RA, et al.. Association of antenatal corticosteroids with mortality and neurodevelopmental outcomes among infants born at 22 to 25 weeks’ gestation. J Am Med Assoc 2011;306:2348–58. https://doi.org/10.1001/jama.2011.1752.Search in Google Scholar PubMed PubMed Central
71. De Jesus, LC, Pappas, A, Shankaran, S, Li, L, Das, A, Bell, EF, et al.. Outcomes of small for gestational age infants born at <27 weeks’ gestation. J Pediatr 2013;163:55–60. https://doi.org/10.1016/j.jpeds.2012.12.097.Search in Google Scholar PubMed PubMed Central
72. Chawla, S, Natarajan, G, Shankaran, S, Pappas, A, Stoll, BJ, Carlo, WA, et al.. Association of neurodevelopmental outcomes and neonatal morbidities of extremely premature infants with differential exposure to antenatal steroids. JAMA Pediatr 2016;170:1164–72. https://doi.org/10.1001/jamapediatrics.2016.1936.Search in Google Scholar PubMed PubMed Central
73. Walsh, MC, Bell, EF, Kandefer, S, Saha, S, Carlo, WA, D’Angio, CT, et al.. Neonatal outcomes of moderately preterm infants compared to extremely preterm infants. Pediatr Res 2017;82:297–304. https://doi.org/10.1038/pr.2017.46.Search in Google Scholar PubMed PubMed Central
74. Boghossian, NS, Hansen, NI, Bell, EF, Brumbaugh, JE, Stoll, BJ, Laptook, AR, et al.. Outcomes of extremely preterm infants born to insulin-dependent diabetic mothers. Pediatrics 2016;137:e20153424. https://doi.org/10.1542/peds.2015-3424.Search in Google Scholar PubMed PubMed Central
75. Binet, ME, Bujold, E, Lefebvre, F, Tremblay, Y, Piedboeuf, B. Role of gender in morbidity and mortality of extremely premature neonates. Am J Perinatol 2012;29:159–66. https://doi.org/10.1055/s-0031-1284225.Search in Google Scholar PubMed
76. Qiu, X, Lee, SK, Tan, K, Piedboeuf, B, Canning, R. Comparison of singleton and multiple-birth outcomes of infants born at or before 32 weeks of gestation. Obstet Gynecol 2008;111:365–71. https://doi.org/10.1097/aog.0b013e318162688f.Search in Google Scholar PubMed
77. Qiu, X, Lodha, A, Shah, PS, Sankaran, K, Seshia, MMK, Yee, W, et al.. Neonatal outcomes of small for gestational age preterm infants in Canada. Am J Perinatol 2012;29:87–94. https://doi.org/10.1055/s-0031-1295647.Search in Google Scholar PubMed
78. Wong, J, Shah, PS, Yoon, EW, Yee, W, Lee, S, Dow, K. Inotrope use among extremely preterm infants in Canadian neonatal intensive care units: variation and outcomes. Am J Perinatol 2015;32:9–14. https://doi.org/10.1055/s-0034-1371703.Search in Google Scholar PubMed
79. Rolnitsky, A, Lee, SK, Piedbouf, B, Harrison, A, Shah, PS. Prophylactic interventions in neonatology: how do they fare in real life? Am J Perinatol 2015;32:1098–104. https://doi.org/10.1055/s-0035-1556882.Search in Google Scholar PubMed
80. Asztalos, EV, Church, PT, Riley, P, Fajardo, C, Shah, PS. Neonatal factors associated with a good neurodevelopmental outcome in very preterm infants. Am J Perinatol 2017;34:388–96. https://doi.org/10.1055/s-0036-1592129.Search in Google Scholar PubMed
81. Isayama, T, Lee, SK, Yang, J, Lee, D, Daspal, S, Dunn, M, et al.. Revisiting the definition of bronchopulmonary dysplasia: effect of changing panoply of respiratory support for preterm neonates. JAMA Pediatr 2017;171:271–9. https://doi.org/10.1001/jamapediatrics.2016.4141.Search in Google Scholar PubMed
82. St Peter, D, Gandy, C, Hoffman, SB. Hypotension and adverse outcomes in prematurity: comparing definitions. Neonatology 2017;111:228–33. https://doi.org/10.1159/000452616.Search in Google Scholar PubMed
83. Younge, N, Smith, PB, Gustafson, KE, Malcolm, W, Ashley, P, Cotten, CM, et al.. Improved survival and neurodevelopmental outcomes among extremely premature infants born near the limit of viability. Early Hum Dev 2016;95:5–8. https://doi.org/10.1016/j.earlhumdev.2016.01.015.Search in Google Scholar PubMed PubMed Central
84. Trittmann, JK, Nelin, LD, Klebanoff, MA. Bronchopulmonary dysplasia and neurodevelopmental outcome in extremely preterm neonates. Eur J Pediatr 2013;172:1173–80. https://doi.org/10.1007/s00431-013-2016-5.Search in Google Scholar PubMed PubMed Central
85. Goldstein, RF, Cotten, CM, Shankaran, S, Gantz, MG, Poole, WK. Influence of gestational age on death and neurodevelopmental outcome in premature infants with severe intracranial hemorrhage. J Perinatol 2013;33:25–32. https://doi.org/10.1038/jp.2012.91.Search in Google Scholar PubMed PubMed Central
86. Travers, CP, Clark, RH, Spitzer, AR, Das, A, Garite, TJ, Carlo, WA. Exposure to any antenatal corticosteroids and outcomes in preterm infants by gestational age: prospective cohort study. BMJ 2017;356:j1039. https://doi.org/10.1136/bmj.j1039.Search in Google Scholar
87. Fisher, JG, Jones, BA, Gutierrez, IM, Hull, MA, Kang, KH, Kenny, M, et al.. Mortality associated with laparotomy-confirmed neonatal spontaneous intestinal perforation: a prospective 5-year multicenter analysis. J Pediatr Surg 2014;49:1215–9. https://doi.org/10.1016/j.jpedsurg.2013.11.051.Search in Google Scholar
88. Shah, TA, Meinzen-Derr, J, Gratton, T, Steichen, J, Donovan, EF, Yolton, K, et al.. Hospital and neurodevelopmental outcomes of extremely low-birth-weight infants with necrotizing enterocolitis and spontaneous intestinal perforation. J Perinatol 2012;32:552–8. https://doi.org/10.1038/jp.2011.176.Search in Google Scholar
89. Catov, JM, Scifres, CM, Caritis, SN, Bertolet, M, Larkin, J, Parks, WT. Neonatal outcomes following preterm birth classified according to placental features. Am J Obstet Gynecol 2017;216:411.e1–e14. https://doi.org/10.1016/j.ajog.2016.12.022.Search in Google Scholar
90. Crane, JMG, Magee, LA, Lee, T, Synnes, A, von Dadelszen, P, Dahlgren, L, et al.. Maternal and perinatal outcomes of pregnancies delivered at 23 weeks’ gestation. J Obstet Gynaecol Can 2015;37:214–24. https://doi.org/10.1016/s1701-2163(15)30307-8.Search in Google Scholar
91. Inomata, K, Taniguchi, S, Yonemoto, H, Inoue, T, Kawase, A, Kondo, Y. Lower early postnatal oxygen saturation target and risk of ductus arteriosus closure failure. Pediatr Int 2016;58:1153–7. https://doi.org/10.1111/ped.12987.Search in Google Scholar PubMed
92. Poon, WB, Ho, SKY, Yeo, CL. Short- and long-term outcomes at 2, 5 and 8 years old for neonates at borderline viability – an 11-year experience. Ann Acad Med Singapore 2013;42:7–17.10.47102/annals-acadmedsg.V42N1p7Search in Google Scholar
93. Nakanishi, H, Uchiyama, A, Kusuda, S. Impact of pulmonary hypertension on neurodevelopmental outcome in preterm infants with bronchopulmonary dysplasia: a cohort study. J Perinatol 2016;36:890–6. https://doi.org/10.1038/jp.2016.108.Search in Google Scholar PubMed PubMed Central
94. Chee, YY, Wong, MS, Wong, RM, Wong, KY. Neonatal outcomes of preterm or very-low-birth-weight infants over a decade from Queen Mary Hospital, Hong Kong: comparison with the Vermont Oxford Network. Hong Kong Med J 2017;23:381–6. https://doi.org/10.12809/hkmj166064.Search in Google Scholar PubMed
95. Imamura, T, Sato, M, Go, H, Ogasawara, K, Kanai, Y, Maeda, H, et al.. The microbiome of the lower respiratory tract in premature infants with and without severe bronchopulmonary dysplasia. Am J Perinatol 2017;34:80–7. https://doi.org/10.1055/s-0036-1584301.Search in Google Scholar PubMed
96. Chen, HJ, Hsu, CH, Chiang, BL. Serum retinol levels and neonatal outcomes in preterm infants. J Formos Med Assoc 2017;116:626–33. https://doi.org/10.1016/j.jfma.2017.04.019.Search in Google Scholar PubMed
97. Ogawa, R, Mori, R, Iida, K, Uchida, Y, Oshiro, M, Kageyama, M, et al.. Effects of the early administration of sivelestat sodium on bronchopulmonary dysplasia in infants: a retrospective cohort study. Early Hum Dev 2017;115:71–6. https://doi.org/10.1016/j.earlhumdev.2017.09.016.Search in Google Scholar PubMed
98. Isayama, T, Lee, SK, Mori, R, Kusuda, S, Fujimura, M, Ye, XY, et al.. Comparison of mortality and morbidity of very low birth weight infants between Canada and Japan. Pediatrics 2012;130:e957–65. https://doi.org/10.1542/peds.2012-0336.Search in Google Scholar PubMed
99. Yamakawa, T, Itabashi, K, Kusuda, S. Mortality and morbidity risks vary with birth weight standard deviation score in growth restricted extremely preterm infants. Early Hum Dev 2016;92:7–11. https://doi.org/10.1016/j.earlhumdev.2015.10.019.Search in Google Scholar PubMed
100. Agarwal, P, Sriram, B, Lim, SB, Tin, AS, Rajadurai, VS. Borderline viability–neonatal outcomes of infants in Singapore over a period of 18 years (1990–2007). Ann Acad Med Singapore 2013;42:328–37.10.47102/annals-acadmedsg.V42N7p328Search in Google Scholar
101. Agarwal, P, Sriram, B, Rajadurai, VS. Neonatal outcome of extremely preterm Asian infants ≤28 weeks over a decade in the new millennium. J Perinatol 2015;35:297–303. https://doi.org/10.1038/jp.2014.205.Search in Google Scholar PubMed
102. Sriram, B, Agarwal, PK, Tee, NWS, Rajadurai, VS. Systemic candidiasis in extremely low birthweight (ELBW) neonates despite the routine use of topical miconazole prophylaxis: trends, risk factors and outcomes over an 11-year period. Ann Acad Med Singapore 2014;43:255–62.10.47102/annals-acadmedsg.V43N5p255Search in Google Scholar
103. Su, BH, Hsieh, WS, Hsu, CH, Chang, JH, Lien, R, Lin, CH. Neonatal outcomes of extremely preterm infants from Taiwan: comparison with Canada, Japan, and the USA. Pediatr Neonatol 2015;56:46–52. https://doi.org/10.1016/j.pedneo.2014.05.002.Search in Google Scholar PubMed
104. Rahman, A, Abdellatif, M, Sharef, SW, Fazalullah, M, Al-Senaidi, K, Khan, AA, et al.. Changing survival rate of infants born before 26 gestational weeks: single-centre study. Sultan Qaboos Univ Med J 2015;15:e351–6. https://doi.org/10.18295/squmj.2015.15.03.008.Search in Google Scholar PubMed PubMed Central
105. Lee, HJ, Lee, BS, Do, HJ, Oh, SH, Choi, YS, Chung, SH, et al.. Early sodium and fluid intake and severe intraventricular hemorrhage in extremely low birth weight infants. J Korean Med Sci 2015;30:283–9. https://doi.org/10.3346/jkms.2015.30.3.283.Search in Google Scholar PubMed PubMed Central
106. Chen, HJ, Wei, KL, Zhou, CL, Yao, YJ, Yang, YJ, Fan, XF, et al.. Incidence of brain injuries in premature infants with gestational age ≤34 weeks in ten urban hospitals in China. World J Pediatr 2013;9:17–24. https://doi.org/10.1007/s12519-012-0395-8.Search in Google Scholar PubMed
107. Iijima, S, Arai, H, Ozawa, Y, Kawase, Y, Uga, N. Clinical patterns in extremely preterm (22 to 24 weeks of gestation) infants in relation to survival time and prognosis. Am J Perinatol 2009;26:399–406. https://doi.org/10.1055/s-0029-1214234.Search in Google Scholar PubMed
108. Kim, JK, Chang, YS, Sung, S, Ahn, SY, Yoo, HS, Park, WS. Trends in survival and incidence of bronchopulmonary dysplasia in extremely preterm infants at 23–26 weeks gestation. J Korean Med Sci 2016;31:423–9. https://doi.org/10.3346/jkms.2016.31.3.423.Search in Google Scholar PubMed PubMed Central
109. Kong, M, Shin, DH, Kim, SJ, Ham, DI, Kang, SW, Chang, YS, et al.. Retinopathy of prematurity in infants born before 25 weeks gestation in a Korean single neonatal intensive care unit: incidence, natural history and risk factors. J Korean Med Sci 2012;27:1556–62. https://doi.org/10.3346/jkms.2012.27.12.1556.Search in Google Scholar PubMed PubMed Central
110. High Risk Follow-up Working Group (Kowloon Region). Neurodevelopmental outcomes of extreme-low-birth-weight infants born between 2001 and 2002. Hong Kong Med J 2008;14:21–8.Search in Google Scholar
111. Zhou, WQ, Mei, YB, Zhang, XY, Li, QP, Kong, XY, Feng, ZC. Neonatal outcomes of very preterm infants from a neonatal intensive care center. World J Pediatr 2014;10:53–8. https://doi.org/10.1007/s12519-013-0445-x.Search in Google Scholar PubMed
112. Kai, K, Sameshima, H, Ikeda, T, Ikenoue, T. Severe variable deceleration is associated with intestinal perforation in infants born at 22–27 weeks’ gestation. J Matern Fetal Neonatal Med 2009;22:259–64. https://doi.org/10.1080/14767050802379049.Search in Google Scholar PubMed
113. Furukawa, S, Sameshima, H, Ikenoue, T. Circulatory disturbances during the first postnatal 24 hours in extremely premature infants 25 weeks or less of gestation with histological fetal inflammation. J Obstet Gynaecol Res 2008;34:27–33. https://doi.org/10.1111/j.1447-0756.2007.00678.x.Search in Google Scholar PubMed
114. We, JS, Park, IY, Jang, DG, Choi, SK, Lee, GS, Shin, JC. Optimal gestational age of delivery to decrease neonatal morbidity in preterm pregnancies in Korea. J Obstet Gynaecol Res 2011;37:563–70. https://doi.org/10.1111/j.1447-0756.2010.01398.x.Search in Google Scholar PubMed
115. Boland, RA, Davis, PG, Dawson, JA, Doyle, LW. Outcomes of infants born at 22–27 weeks’ gestation in Victoria according to outborn/inborn birth status. Arch Dis Child Fetal Neonatal Ed 2017;102:F153–61. https://doi.org/10.1136/archdischild-2015-310313.Search in Google Scholar PubMed
116. Heald, A, Abdel-Latif, ME, Kent, AL. Insulin infusion for hyperglycaemia in very preterm infants appears safe with no effect on morbidity, mortality and long-term neurodevelopmental outcome. J Matern Fetal Neonatal Med 2012;25:2415–8. https://doi.org/10.3109/14767058.2012.699115.Search in Google Scholar PubMed
117. Kent, AL, Wright, IM, Abdel-Latif, ME. Mortality and adverse neurologic outcomes are greater in preterm male infants. Pediatrics 2012;129:124–31. https://doi.org/10.1542/peds.2011-1578.Search in Google Scholar PubMed
118. Seth, R, Gray, PH, Tudehope, DI. Decreased use of postnatal corticosteroids in extremely preterm infants without increasing chronic lung disease. Neonatology 2009;95:172–8. https://doi.org/10.1159/000153102.Search in Google Scholar PubMed
119. Wong, D, Abdel-Latif, ME, Kent, AL. Antenatal steroid exposure and outcomes of very premature infants: a regional cohort study. Arch Dis Child Fetal Neonatal Ed 2014;99:F12–20. https://doi.org/10.1136/archdischild-2013-304705.Search in Google Scholar PubMed
120. Hintz, SR, Slovis, T, Bulas, D, Van Meurs, KP, Perritt, R, Stevenson, DK, et al.. Interobserver reliability and accuracy of cranial ultrasound scanning interpretation in premature infants. J Pediatr 2007;150:592–6, 596.e1–5. https://doi.org/10.1016/j.jpeds.2007.02.012.Search in Google Scholar PubMed PubMed Central
121. Brouwer, AJ, Groenendaal, F, Benders, MJ, de Vries, LS. Early and late complications of germinal matrix-intraventricular haemorrhage in the preterm infant: what is new? Neonatology 2014;106:296–303. https://doi.org/10.1159/000365127.Search in Google Scholar PubMed
122. Rademaker, KJ, Uiterwaal, CS, Beek, FJ, van Haastert, IC, Lieftink, AF, Groenendaal, F, et al.. Neonatal cranial ultrasound versus MRI and neurodevelopmental outcome at school age in children born preterm. Arch Dis Child Fetal Neonatal Ed 2005;90:F489–93. https://doi.org/10.1136/adc.2005.073908.Search in Google Scholar PubMed PubMed Central
Supplementary Material
The online version of this article offers supplementary material (https://doi.org/10.1515/jpm-2020-0331).
© 2021 Csaba Siffel et al., published by De Gruyter, Berlin/Boston
This work is licensed under the Creative Commons Attribution 4.0 International License.
Articles in the same Issue
- Frontmatter
- Review
- Global incidence of intraventricular hemorrhage among extremely preterm infants: a systematic literature review
- Commentary
- Professional integrity in maternal – fetal innovation and research: an essential component of perinatal medicine
- WAPM Recommendations
- WAPM-World Association of Perinatal Medicine Practice Guidelines: Fetal central nervous system examination
- Corner of Academy
- Education in developing countries and reducing maternal mortality: a forgotten piece of the puzzle?
- Original Articles – Obstetrics
- The contemporary value of dedicated preterm birth clinics for high-risk singleton pregnancies: 15-year outcomes from a leading maternal centre
- Chorioamnionitis after premature rupture of membranes in nulliparas undergoing labor induction: prostaglandin E2 vs. oxytocin
- Maternal and fetal outcomes in pregnancies with obstructive sleep apnea
- Assessing the involvement of the placental microbiome and virome in preeclampsia using non coding RNA sequencing
- Risk of metformin failure in the treatment of women with gestational diabetes
- Can we improve our ability to interpret category II fetal heart rate tracings using additional clinical parameters?
- New obstetric systemic inflammatory response syndrome criteria for early identification of high-risk of sepsis in obstetric patients
- Bacteria in the amniotic fluid without inflammation: early colonization vs. contamination
- Intertwin differences in umbilical artery pulsatility index are associated with infant survival in twin-to-twin transfusion syndrome
- Maternal and neonatal outcomes in women with disorders of lipid metabolism
- The use of PAMG-1 testing in patients with preterm labor, intact membranes and a short sonographic cervix reduces the rate of unnecessary antenatal glucocorticoid administration
- Original Articles – Neonates
- The effect of postnatal corticosteroids on growth parameters in infants with bronchopulmonary dysplasia
- Are neonatal outcomes of triplet pregnancies different from those of singletons according to gestational age?
- Impact of paternal presence and parental social-demographic characteristics on birth outcomes
- Letter to the Editor
- Comment on: “amniotic fluid embolism – implementation of international diagnosis criteria and subsequent pregnancy recurrence risk”
Articles in the same Issue
- Frontmatter
- Review
- Global incidence of intraventricular hemorrhage among extremely preterm infants: a systematic literature review
- Commentary
- Professional integrity in maternal – fetal innovation and research: an essential component of perinatal medicine
- WAPM Recommendations
- WAPM-World Association of Perinatal Medicine Practice Guidelines: Fetal central nervous system examination
- Corner of Academy
- Education in developing countries and reducing maternal mortality: a forgotten piece of the puzzle?
- Original Articles – Obstetrics
- The contemporary value of dedicated preterm birth clinics for high-risk singleton pregnancies: 15-year outcomes from a leading maternal centre
- Chorioamnionitis after premature rupture of membranes in nulliparas undergoing labor induction: prostaglandin E2 vs. oxytocin
- Maternal and fetal outcomes in pregnancies with obstructive sleep apnea
- Assessing the involvement of the placental microbiome and virome in preeclampsia using non coding RNA sequencing
- Risk of metformin failure in the treatment of women with gestational diabetes
- Can we improve our ability to interpret category II fetal heart rate tracings using additional clinical parameters?
- New obstetric systemic inflammatory response syndrome criteria for early identification of high-risk of sepsis in obstetric patients
- Bacteria in the amniotic fluid without inflammation: early colonization vs. contamination
- Intertwin differences in umbilical artery pulsatility index are associated with infant survival in twin-to-twin transfusion syndrome
- Maternal and neonatal outcomes in women with disorders of lipid metabolism
- The use of PAMG-1 testing in patients with preterm labor, intact membranes and a short sonographic cervix reduces the rate of unnecessary antenatal glucocorticoid administration
- Original Articles – Neonates
- The effect of postnatal corticosteroids on growth parameters in infants with bronchopulmonary dysplasia
- Are neonatal outcomes of triplet pregnancies different from those of singletons according to gestational age?
- Impact of paternal presence and parental social-demographic characteristics on birth outcomes
- Letter to the Editor
- Comment on: “amniotic fluid embolism – implementation of international diagnosis criteria and subsequent pregnancy recurrence risk”